相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Thromboxane A2 Receptor-Driven COX-2-Dependent Feedback Loop That Affects Endothelial Homeostasis and Angiogenesis
Robert Eckenstaler et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2022)
15-F2t-Isoprostane Favors an Anti-Inflammatory Phenotype in RAW 264.7 Macrophages during Endotoxin Challenge
Ashley K. Putman et al.
ANTIOXIDANTS (2022)
Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease
William Herrington et al.
CIRCULATION RESEARCH (2016)
GPCR-mediated EGF receptor transactivation regulates TRPV4 action in the vasculature
Mahmoud Saifeddine et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activation
Jochen Bauer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Ceacam1 deletion causes vascular alterations in large vessels
Sonia M. Najjar et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2013)
Thromboxane Receptors in Smooth Muscle Promote Hypertension, Vascular Remodeling, and Sudden Death
Matthew A. Sparks et al.
HYPERTENSION (2013)
Allergic inflammation induces a persistent mechanistic switch in thromboxane-mediated airway constriction in the mouse
Jaime M. Cyphert et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2012)
Daily administration of the TP receptor antagonist terutroban improved endothelial function in high-cardiovascular-risk patients with atherosclerosis
Pierre-Francois Lesault et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Atherosclerosis: current pathogenesis and therapeutic options
Christian Weber et al.
NATURE MEDICINE (2011)
Expression of thromboxane synthase, prostacyclin synthase and thromboxane receptor in atherosclerotic lesions: Correlation with plaque composition
Tillmann Cyrus et al.
ATHEROSCLEROSIS (2010)
Interaction of Thiazolidinediones (Glitazones) with the ATP-Binding Cassette Transporters P-Glycoprotein and Breast Cancer Resistance Protein
Johanna Weiss et al.
PHARMACOLOGY (2009)
Isoprostanes Inhibit Vascular Endothelial Growth Factor-Induced Endothelial Cell Migration, Tube Formation, and Cardiac Vessel Sprouting In Vitro, As Well As Angiogenesis In Vivo via Activation of the Thromboxane A2 Receptor A Potential Link Between Oxidative Stress and Impaired Angiogenesis
Ralf A. Benndorf et al.
CIRCULATION RESEARCH (2008)
Mass spectrometric analysis of F2-isoprostanes:: Markers and mediators in human disease
Edzard Schwedhelm et al.
CURRENT PHARMACEUTICAL ANALYSIS (2007)
Involvement of thromboxane receptor in the proatherogenic effect of isoprostane F2α-III Evidence from apolipoprotein E- and LDL receptor-deficient mice
M Tang et al.
CIRCULATION (2005)
Cyclopentenone isoprostanes inhibit the inflammatory response in macrophages
ES Musiek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Cyclooxygenase 1-dependent production of F2-isoprostane and changes in redox status during warm renal ischemia-reperfusion
F Favreau et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Urinary 8-iso-prostaglandin F2α as a risk marker in patients with coronary heart disease -: A matched case-control study
E Schwedhelm et al.
CIRCULATION (2004)
Role for thromboxane receptors in angiotensin-II-Induced hypertension
H Francois et al.
HYPERTENSION (2004)
Roles of thromboxane A2 and prostacyclin in the development of atherosclerosis in apoE-deficient mice
T Kobayashi et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
LRP: Role in vascular wall integrity and protection from atherosclerosis
P Boucher et al.
SCIENCE (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Thromboxane receptor density is increased in human cardiovascular disease with evidence for inhibition at therapeutic concentrations by the AT1 receptor antagonist losartan
SD Katugampola et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
The isoprostane 8-iso-PGF2α stimulates endothelial cells to bind monocytes:: differences from thromboxane-mediated endothelial activation
N Leitinger et al.
FASEB JOURNAL (2001)
Conditional vascular cell adhesion molecule 1 deletion in mice: Impaired lymphocyte migration to bone marrow
PA Koni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Reversal of angiogenesis in vitro, induction of apoptosis, and inhibition of Akt phosphorylation in endothelial cells by thromboxane A2
YL Gao et al.
CIRCULATION RESEARCH (2000)
The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apo E-deficient mice - Evidence that eicosanoids other than thromboxane contribute to atherosclerosis
AJ Cayatte et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Cardiovascular responses to the isoprostanes iPF2α-III and iPE2-III are mediated via the thromboxane A2 receptor in vivo
LP Audoly et al.
CIRCULATION (2000)
Human internal mammary artery contraction by isoprostaglandin F2α type-III (8-iso-prostaglandin F2α)
JL Cracowski et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
分享论文
